Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Robin

Showing results (261-270 of 298) with videos related to

Pageof 30
Sort By:
Bone Marrow Transplantation|January 10, 2024
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Diderik-Jan Eikema, Linda Koster, et al.
American Journal of Hematology|October 16, 2020
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)Nicola Polverelli, Katya Mauff, Nicolaus Kröger, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2025
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, et al.
Blood|June 6, 2022
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysisMarie Robin, Liesbeth C de Wreede, Eric Padron, et al.
Bone Marrow Transplantation|August 31, 2023
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TCGaëlle Rey, Elisabeth Daguenet, Paul Bonjean, et al.
American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.
British Journal of Haematology|May 30, 2018
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMTDonal P McLornan, Richard Szydlo, Marie Robin, et al.
Bone Marrow Transplantation|September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTJuan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Blood Advances|November 19, 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosisDamien Luque Paz, Nico Gagelmann, Lina Benajiba, et al.
American Journal of Hematology|November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMTAlicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Pageof 30

Showing results (261-270 of 298) with videos related to

Sort By:
Pageof 30
Bone Marrow Transplantation|January 10, 2024
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Diderik-Jan Eikema, Linda Koster, et al.
American Journal of Hematology|October 16, 2020
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)Nicola Polverelli, Katya Mauff, Nicolaus Kröger, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2025
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, et al.
Blood|June 6, 2022
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysisMarie Robin, Liesbeth C de Wreede, Eric Padron, et al.
Bone Marrow Transplantation|August 31, 2023
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TCGaëlle Rey, Elisabeth Daguenet, Paul Bonjean, et al.
American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.
British Journal of Haematology|May 30, 2018
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMTDonal P McLornan, Richard Szydlo, Marie Robin, et al.
Bone Marrow Transplantation|September 7, 2023
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTJuan Carlos Hernández-Boluda, Diderik-Jan Eikema, Linda Koster, et al.
Blood Advances|November 19, 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosisDamien Luque Paz, Nico Gagelmann, Lina Benajiba, et al.
American Journal of Hematology|November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMTAlicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Pageof 30